AIA
BHC icon

Allegis Investment Advisors’s Bausch Health BHC Stock Holding History

Allegis Investment Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-490
Closed -$50K – 260
2015
Q4 		$50K Buy
+490
New +$55.1K 0.03% 330

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Allegis Investment Advisors's BHC Position: Q1 2016 in Review

Allegis Investment Advisors sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 490 shares — an estimated $50K sold.

Allegis Investment Advisors first reported a position in BHC in Q4 2015 and held it in 1 quarter. The position peaked at $50K in Q4 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Allegis Investment Advisors reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 490 Bausch Health shares in Q1 2016, an estimated $50K.
  • Allegis Investment Advisors first reported a position in Bausch Health in Q4 2015 and held it in 1 quarter.
  • Allegis Investment Advisors's Bausch Health position peaked at $50K in Q4 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Allegis Investment Advisors's 13F filing for Q1 2016, filed 9 May 2016.